Patent Assignment
Reel/Frame 030230/0819
Assignment of Assignor's Interest
Recorded: 2013-04-17
Pages: 14
Assignor
HYBRID BIOSYSTEMS LIMITED
Executed: 2011-05-06
Assignee
PSIOXUS THERAPEUTICS LIMITED
5 NEW LONDON SQUARE, LONDON, EC4A 3TW, UNITED KINGDOM
Covered Property
(1)
Chimeric Adenoviruses for Use in Cancer Treatment
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 17, 2013
From: HARDEN, PAUL; HERMISTON, TERRY; KUHN, IRENE
To: SCHERING AKTIENGESELLSCHAFT
Reel/Frame 030230/0685 →
Assignment of Assignor's Interest
Apr 17, 2013
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: HYBRID BIOSYSTEMS LIMITED
Reel/Frame 030230/0777 →
Change of Name
Apr 17, 2013
From: SCHERING AKTIENGESELLSCHAFT
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 030230/0836 →
Change of Name
Feb 8, 2023
From: PSIOXUS THERAPEUTICS LIMITED
To: AKAMIS BIO LIMITED
Reel/Frame 062681/0495 →
Change of Address
Feb 8, 2023
From: AKAMIS BIO LIMITED
To: AKAMIS BIO LIMITED
Reel/Frame 062681/0504 →
Assignment of Assignor's Interest
Jan 23, 2026
From: AKAMIS BIO LIMITED
To: AKAMIS BIO, INC.
Reel/Frame 073559/0435 →